1. Aisner J, Belani CP (1993) Lung Cancer: Recent changes and expectations of improvements. Sem Oncol 20: 383–393
2. Aisner J, Alberto P, Bitran J, Comis R, Daniels J, Hansen HH, Smyth J (1983) Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. Cancer Treatm Rep 67: 37–43
3. Aisner J, Whitcare M, Echo DA van, Fuks JZ (1984) Cyclophosphamide, doxorubicin and etoposide (CAE) for the treatment of small cell lung cancer. In: Issel BF, Muggia FM, Carter SK (eds) Etoposide (VP-16). Current status and new developments. Academic Press, New York, pp 171–182
4. Allan SG, Gregor A, Cornbleet MA, Leonard RCF, Smyth JF, Grant IWB, Crompton GK (1984) Phase II trial of vindesine and VP 16 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pnarmacol 13: 106–108
5. Bishop JF (1993) The role of colony-stimulating factors in small cell lung cancer. Lung Cancer 9 (Suppl 1): 75–83